PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,377
- 试验地点
- 1
- 主要终点
- PrEP Prescriptions
研究概览
简要总结
The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Patient of UAB GYN clinic
排除标准
- •Not a patient of UAB GYN clinic
研究组 & 干预措施
Sexual Health-PRO
Patients seen during routine GYN clinic visit.
干预措施: PrEP acronym (pre-exposure prophylaxis) (Behavioral)
Post visit (fidelity) survey
Patients who completed the survey outside of clinic visit
干预措施: PrEP acronym (pre-exposure prophylaxis) (Behavioral)
结局指标
主要结局
PrEP Prescriptions
时间窗: 8 months
Number of participants receiving a new PrEP prescription during the recruitment period
次要结局
未报告次要终点
研究者
Michael J Mugavero, MD
Professor
University of Alabama at Birmingham
